XYMBISPHERE
Live / Applied — Fourth extension granted (statement of use) (as of 28 Aug 2025)
What this means for you
Not registered yet, but its 12 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97408278
- Mark type
- Stylized text
- Filed
- 12 May 2022
- Published for opposition
- 18 Jul 2023
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prosecution history
- 04 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Aug 2025 — SOU EXTENSION 4 GRANTED
- 28 Aug 2025 — SOU EXTENSION 4 FILED
- 28 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jan 2025 — SOU EXTENSION 3 GRANTED
- 17 Jan 2025 — SOU EXTENSION 3 FILED
- 17 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Aug 2024 — SOU EXTENSION 2 GRANTED
- 09 Aug 2024 — SOU EXTENSION 2 FILED
- 09 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 15 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2024 — SOU EXTENSION 1 GRANTED